Breast Cancer Therapy
Research conducted at Chester Beatty Laboratories has updated our knowledge about breast cancer therapy
Published in Lab Business Week, August 19th, 2007
Researchers detail in "Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes," new data in breast cancer. In this recently published article, scientists in London, the United Kingdom conducted a study "To analyze epigenetic regulation of two related genes, insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) and IGFBPL1, and its significance as a determinant of clinical phenotypes in human breast cancer. We have investigated the expression and epigenetic regulation of IGFBP-rP1 and IGFBPL1 in human breast cancer cell lines and primary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-08-19)
More Articles from Lab Business Week
- Allergies
Auriga Laboratories Expands the Zinx Family with the Launch of Two New Prescription Convenience Kits - Zinx Allergy Kit and Zinx Kids' Sneeze Kit - Antibiotics
Findings from Dr. Reddy's Laboratories Ltd. advance knowledge in antibiotics - Cell Biology
Cold Spring Harbor Laboratory reports research in cell biology - Chemotherapy
Reports outline chemotherapy research from Mitsubishi Kagaku Bio-Clinical Laboratories, Inc. - Clinical Trial Research
Rheoscience and Dr. Reddy's Commence the First Phase III Trial of Balaglitazone (DRF 2593) - Drug Resistance
Study results from JMI Laboratories Inc. broaden understanding of drug resistance - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
